Theriva Biologics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2010 | $-1.1M | $-1.2M | $12.0K | $400.0K |
| FY2011 | $-2.9M | $-2.9M | $0 | $973.0K |
| FY2012 | $-8.9M | $-8.9M | $10.0K | $1.9M |
| FY2013 | $-7.7M | $-7.8M | $36.0K | $1.7M |
| FY2014 | $-16.1M | $-16.1M | $48.0K | $2.5M |
| FY2015 | $-38.9M | $-39.4M | $501.0K | $3.2M |
| FY2016 | $-27.9M | $-28.5M | $569.0K | $4.0M |
| FY2017 | $-20.2M | $-20.4M | $212.0K | $3.4M |
| FY2018 | $-17.3M | $-17.3M | $7.0K | $2.1M |
| FY2019 | $-13.9M | $-13.9M | $0 | $340.0K |
| FY2020 | $-12.2M | $-12.2M | $9.0K | $350.0K |
| FY2021 | $-12.9M | $-12.9M | $14.0K | $416.0K |
| FY2022 | $-19.1M | $-19.2M | $116.0K | $475.0K |
| FY2023 | $-19.0M | $-19.2M | $202.0K | $552.0K |
| FY2024 | $-16.9M | $-16.9M | $1.0K | $671.0K |
| FY2025 | $-16.7M | $-16.7M | $35.0K | $654.0K |